Dr. Michael Lawrence Shelling, MD

Dr. Shelling practices at Michael L. Shelling, MD in Boynton Beach, Florida.

Dr. Shelling's NPI, 1598924896, was assigned on June 3, 2008. Dr. Shelling graduated from University of Miami, Miller School of Medicine in 2008. Dr. Shelling holds Florida license ME111217.

Dr. Shelling's primary practice is Michael L. Shelling, MD, at 10075 S Jog Rd, Boynton Beach, FL 33437 in Palm Beach County. The practice phone is (561) 737-1100.

Dr. Shelling's primary practice is Michael L. Shelling, MD in Boynton Beach, Florida. The medical group on file is Shelling Dermatology. Dmand AI also links Dr. Shelling to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Shelling practices. Vendor and product names are available with a free account.

Dermatology is Dr. Shelling's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Shelling is board certified in dermatology by the American Board of Dermatology. Dr. Shelling is licensed in Florida.

Dmand AI lists acne, acute skin infection, benign or precancerous skin growths, cancerous skin growth removal, cold sores or genital herpes, contact dermatitis, facial skin infection and hives among the conditions Dr. Shelling treats.

CMS data shows 13,784 Medicare services from Dr. Shelling across 32 procedure codes in 2024, for 1,888 Medicare patients. Medicare paid $909,104 for them. Every service was in an office.

CMS counts 1,888 Medicare patients who saw Dr. Shelling in 2024. The largest group is 75 to 84, with 986 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 1% are also on Medicaid. Their average risk score is 1.27, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Shelling's median patient age at 79, with 51% women.

In 2024, Dr. Shelling wrote 2,099 Medicare Part D claims for 869 patients. 96% of them were for generic drugs. CMS names the drug for 1,893 of them, across 26 drugs with 11 or more claims each, at $219,011 in total drug cost. In 2023, CMS named 1,830 claims across 24 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Shelling for performance year 2024, reported individually. Dr. Shelling accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 3,670 procedures of removal of skin lesions by Dr. Shelling, more than 99% of the clinicians it reports for that procedure.

Dmand AI links 14 papers to Dr. Shelling in 2012. The most frequent topics are Psoriasis, Comorbidity and Immunocompromised Host. Dr. Shelling has published most often in Arch Dermatol. Dr. Shelling's most frequent co-authors are Robert S. Kirsner, MD, Francisco A. Kerdel, MD and Daniel Glenn Federman, MD.

CMS Open Payments shows 131 general payments to Dr. Shelling from 21 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 99% of the total. Abbvie Inc. paid the most, $802.

Dmand AI lists 2 awards for Dr. Shelling, most recently Dermatology Chief Resident in 2012.

Dr. Shelling graduated from University of Miami, Miller School of Medicine in 2008. Dr. Shelling is a member of AAD and American Society for Mohs Surgery.

Dr. Shelling is in network with 13 carriers, including Aetna, Excellus BlueCross BlueShield and United Healthcare. HMO plans come from the most carriers, 8. Check the plan with the practice before a visit.